Search results for "From ACP Journal Club"


 
Results 61 - 70 of about 131 for "From ACP Journal Club".

Hypoglycemia was associated with increased mortality in ICU patients regardless of glucose control strategy | ACP Diabetes Monthly

A post hoc analysis of the NICE-SUGAR trial that included about 6,000 ICU patients compared intensive glucose control (targeting blood glucose levels of 81 to 108 mg/dL) and conventional glucose control (targeting levels ≤180 mg/dL).

Review: In adult outpatients, nurse-managed protocols improve HbA1c levels and blood pressure | ACP Diabetes Monthly

Medication titration by nurses according to protocols was associated with a modest improvement in control of some chronic diseases, including diabetes, according to a review and meta-analysis.

March 8, 2019 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

December 14, 2012 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Incretin use was not associated with increased risk for acute pancreatitis | ACP Diabetes Monthly

Patients who took incretin-based drugs had the same risk of acute pancreatitis as those who took other hypoglycemic medications or took neither type of drug, a case-control study found.

April 14, 2017 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Telemonitoring was associated with greater mortality and did not reduce hospitalizations or ED visits in high-risk elderly patients | ACP Diabetes Monthly

A trial in four Minnesota primary care clinics randomized high-risk elderly patients to home telemonitoring or usual care.

In patients with type 2 diabetes and CV disease, empagliflozin reduced a composite of CV events at 3.1 years | ACP Diabetes Monthly

An industry-funded trial found that those who took empagliflozin had lower rates of mortality, including from cardiovascular (CV) events, than those on placebo. A commentary in ACP Journal Club called the trial results fascinating but said they are

Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease | ACP Diabetes Monthly

In a meta-analysis, patients with two to four risk factors for diabetes were more likely to have new-onset diabetes if they took higher doses of statins.

December 9, 2016 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next